Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ SARS-CoV-2 Spike (N501Y Mutant) Recombinant Rabbit Monoclonal Antibody (1J5G2)

Rabbit Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA551234

Catalog No. FEMA551234


Only null left
Add to Cart

Description

Description

Immunogen sequence: NYLYRLFRKS NLKPFERDIS TEIYQAGSTP CNGVEGFNCY FPLQSYGFQP TYGVGYQPYR VVVLSFELLH APATVCGPKK STNLVKNKCV NFNFNGLTGT G.

The spike protein in SARS-CoV-2 (SARS-2-S) interacts with the human ACE2 receptor to gain entry into a cell to initiate infection SARS-2-S is cleaved into S1 and S2 subunits, with S1 serving the function of receptor-binding and S2 serving the function of membrane fusion The S protein undergoes two crucial cleavage events, with the first splitting S1 and S2 and the second splitting S2 into FP and S2' [PMID: 33466921].
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SARS-CoV-2 Spike (N501Y Mutant)
Recombinant Monoclonal
1 mg/mL
PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3
Rabbit
Affinity Chromatography
RUO
Virus
Antibody
Liquid
ELISA, Western Blot
1J5G2
Unconjugated
2019-nCoV Spike; COVID-19 Spike; SARS-CoV-2 Spike
A synthetic peptide corresponding to a sequence within amino acids 450-550 of coronavirus SARS-CoV-2 Spike RBD (N501Y) (YP_009724390.1).
100 μL
Primary
-20°C, Avoid Freeze/Thaw Cycles
Liquid
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.